VIRTUS PHARMACEUTICALS OPCO II L
FDA Regulatory Profile
Summary
- Total Recalls
- 7 (3 Class I)
- 510(k) Clearances
- 0
- Inspections
- 2
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|
| D-0241-2017 | Class III | VirtPrex Prenatal/Postnatal Tablets, Prescription Supplement Containing Folic Acid and DHA, packaged | December 12, 2016 |
| D-0238-2017 | Class III | Virt-Advance Prenatal/Postnatal Softgels, Prescription Folic Acid Containing Dietary Supplement, pac | December 12, 2016 |
| D-0240-2017 | Class III | Virt-Select Prenatal/Postnatal Softgels, Prescription Multivitamin/Mineral Dietary Supplement with F | December 12, 2016 |
| D-0239-2017 | Class III | Extra-Virt Plus DHA Prenatal/Postnatal Softgel, Prescription Multivitamin/Mineral Dietary Supplement | December 12, 2016 |
| D-0214-2017 | Class I | Hyoscyamine Sulfate, USP Tablets, 0.125 mg, 100-count tablets per bottle, Rx only, Manufactured for: | September 2, 2016 |
| D-0212-2017 | Class I | Hyoscyamine Sulfate, Sublingual Tablets, 0.125 mg, 100-count bottle, Rx only, Manufactured for: Virt | September 2, 2016 |
| D-0213-2017 | Class I | Hyoscyamine Sulfate, Orally Disintegrating Tablets, 0.125 mg, 100-count bottles, Rx only, Manufactur | September 2, 2016 |